L’Oréal’s BOLD invests in OliX Pharmaceuticals June 9, 2026 OliX Pharmaceuticals has received investment from BOLD, L’Oréal’s corporate venture capital fund, and Weiss Asset Management. Read the full article now! Log in Subscribe